Target-based Drug Repurposing

Target-Based Drug Repurposing is a systematic approach in infectious disease drug discovery that identifies new therapeutic applications for existing compounds by focusing on their interactions with specific molecular targets implicated in pathogen biology or host-pathogen interactions.

106

Publications

5.9K

Citations

633

Authors

282

Institutions

Publications per year

2017–2026

90

Authors

633

  1. YC
    Yoonjung Choi

    University of Pittsburgh, United States

    3 publications · 962 citations

    3

    h-index

  2. BS
    Bonggun Shin

    Emory University, United States

    3 publications · 962 citations

    3

    h-index

  3. KK
    Keunsoo Kang

    Dankook University, South Korea

    3 publications · 962 citations

    3

    h-index

  4. SP
    Sung‐Soo Park

    Catholic University of Korea, South Korea

    3 publications · 962 citations

    3

    h-index

  5. BR
    Bo Ram Beck

    Handong Global University, South Korea

    3 publications · 962 citations

    3

    h-index

1–5 of 633

Venues

  1. ChemRxiv

    Repository · 8 publications · 137 citations

    8

    h-index

  2. bioRxiv (Cold Spring Harbor Laboratory)

    Repository · 4 publications · 273 citations

    4

    h-index

  3. Molecules

    4 publications · 230 citations

    4

    h-index

  4. Computers in Biology and Medicine

    3 publications · 98 citations

    3

    h-index

  5. Life Sciences

    3 publications · 537 citations

    3

    h-index

1–5